How GSK�s Zantac Case Escalated To Become One Of the Biggest Litigations In Medical History

Sharing is caring!

Since September 2019, a widely used drug for gastroenteric problems known as Zantac has faced serious legal issues for containing cancer-causing elements. GlaxoSmithKline (GSK), one of the primary defendants in this litigation, is a reputed player in the pharmaceutical industry that sells numerous medicines helping millions of people around the globe. 

Zantac is the brand name under which GSK sold ranitidine, a drug that people used to take for relief from problems such as heartburn caused by acid indigestion. Finding out they had stomach cancer from the same drug has become a traumatic revelation to many. Search terms such as Zantac stomach cancer, Zantac Liver Cancer, etc., are becoming more and more common as people want to know more about the effects of Zantac, most likely because they used to be regular consumers. 

All of this started when a random quality test by Valisure LLC, an FDA accredited laboratory, found ranitidine to be one of Zantac’s essential ingredients. This contains elements that can form an extremely volatile compound known as NDMA. 

NDMA is a dangerous carcinogen that used to be obtained as a byproduct of manufacturing rocket fuel. NDMA’s only commercial use is to induce cancer development in lab animals. According to FDA norms, exposure above 96 nanograms of NDMA a day is considered dangerous

Yet, recent findings by the Connecticut-based lab facility show that a single dose of Zantac can ingest consumers with up to much more NDMA than the safe limit mentioned above. These findings prompted a ban on Zantac and a global recall of all ranitidine products with immediate effect. 

It also generated hundreds of thousands of class action and mass tort lawsuits by cancer patients who consumed Zantac regularly. The scientific connections continue to evolve with progress in research and testing required for case proceedings. 

It’s been a couple of years since the litigation process began, and it’s picking the pace up with trials scheduled later this year. Further in this post, we will detail the intake criteria you require to meet in order to qualify for possible compensation. 

Criteria

The sheer number of cancer cases prompted top law officers to centralize it as multi-district litigation that will be heard later this year in Miami, Florida. The following are the intake criteria you require to meet to reach a settlement that could potentially mitigate your loss caused by consuming Zantac. 

  • The claimant must specify the etiology of the disease they’re suffering from as a direct result of ranitidine sold by GlaxoSmithKline under the brand Zantac. Mentions of any other ranitidine product will potentially rule you out of the case.
  • According to the latest case updates, the number of cancers that Zantac could cause has come down to just five. A plaintiff will only be eligible for compensation if they have proof that states they suffered from one of the cancers that are currently included in the latest court order.
  • The said disease should not be resultant cancer from another existing health condition. In such a case, your claim will be ruled out as non-viable, even if it was metastasized with Zantac.
  • The diagnosis records must be dated within one year of consuming Zantac.

To Conclude

Over fifty nations worldwide have outright banned the manufacturing and sales of Zantac. The drug that once used to be a sign of relief is presently related to various types of cancers. While we are left with no choice but to face the inevitable effects caused by naturally occurring diseases, those caused by the negligence of duty, ignorance or greed need to be answered for. 

Getting diagnosed with cancer because you consumed a daily drug for something as simple as indigestion is a scandalous waste of time, health and money. If not the whole company, these adversities could result from certain people’s avarice and unwillingness to let the public know of their mistakes.

As we mentioned earlier, ranitidine is linked to several types of cancers. Screening for multiple cancers alone is an expensive procedure, let alone the treatment expenses that could reach hundreds of thousands of dollars. It’s unfair that you have to pay for the mistakes of a multinational pharmaceutical with your health and earnings. 

So, if you think you meet the criteria mentioned above, you might stand a chance to present a valid claim that can potentially fetch you compensation in the Zantac MDL. We recommend that you reach out to an experienced and reputed mass tort lawyer for advice on furthering your claim.

Sharing is caring!

Speak Your Mind

*